Page last updated: 2024-10-28

heptaminol and Idiopathic Parkinson Disease

heptaminol has been researched along with Idiopathic Parkinson Disease in 1 studies

Heptaminol: An amino alcohol that has been used as a myocardial stimulant and vasodilator and to relieve bronchospasm. Its most common therapeutic use is in orthostatic hypotension. The mechanism of heptaminol's therapeutic actions is not well understood although it has been suggested to affect catecholamine release or calcium metabolism.

Research Excerpts

ExcerptRelevanceReference
"Heptaminol is a molecule with experimental cardiovascular analeptic properties."2.67Randomized double-blind trial of injectable heptaminol for controlling spontaneous or bromocriptine-induced orthostatic hypotension in parkinsonians. ( Allain, H; Milon, D; Morel, G; Reymann, JM; Sabouraud, O; Van den Driessche, J, 1990)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Milon, D1
Allain, H1
Reymann, JM1
Morel, G1
Sabouraud, O1
Van den Driessche, J1

Trials

1 trial available for heptaminol and Idiopathic Parkinson Disease

ArticleYear
Randomized double-blind trial of injectable heptaminol for controlling spontaneous or bromocriptine-induced orthostatic hypotension in parkinsonians.
    Fundamental & clinical pharmacology, 1990, Volume: 4, Issue:6

    Topics: Blood Pressure; Bromocriptine; Double-Blind Method; Female; Heart Rate; Heptaminol; Humans; Hypotens

1990